Patient (n) | 24 | Range | IQR |
---|---|---|---|
Age (years) | 63 | (39–80) | 56–70 |
Sex (%) | |||
Men, n (%) | 19 (79%) | ||
Women, n (%) | 5 (21%) | ||
BCLC, n (%) | |||
0 | 5 (21%) | ||
A | 17 (71%) | ||
B | 2 (8%) | ||
CHILD | |||
A | |||
A5 | 15 (63%) | ||
A6 | 5 (21%) | ||
B | |||
B7 | 4 (17%) | ||
Baseline analysis | |||
Br | 0.9 | (0.3–4.1) | 0.5–1 |
Alb | 4.01 | (2.5–4.8) | 3.7–4.5 |
ALT | 37.9 | (16–82) | 25–49 |
AST | 38.3 | (20–50) | 31–47 |